Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine–venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net

期刊论文
出版模式：

开放获取
发表日期：

2025年7月3日

查看全文

Minoru Kanaya,
Masahiro Onozawa,
Toshihiro Matsukawa,
Naoki Miyashita,
Fumiaki Fujii,
Shota Yoshida,
Jun Nagai,
Masayuki Aiba,
Daisuke Hidaka,
Junichi Hashiguchi,
Hajime Senjo,
Tetsuyuki Igarashi,
Masahiro Chiba,
Satoshi Yamamoto,
Taku Shimizu,
Takashi Ishio,
Shota Yokoyama,
Ko Ebata,
Satoshi Iyama,
Tatsuo Oyake,
Takeshi Kondo,
Takanori Teshima

本文未提供摘要，请点击“查看全文”查看完整内容。